Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Kelindi | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
A coronavirus pandemic began on 12/31/2019 with a first Chinese patient. As of 04/04/2020, the epidemic affects more than 190 countries with more than 50 million official contaminations and 1,251,000 deaths. (Univ J Hopkins). This virus causes a pathology ranging from simple flu-like symptoms in 80% of cases to acute respiratory distress syndromes requiring intensive care in 5% of cases and a death rate of 1.4 to 4% of cases.
Viral contamination is airborne and fecal A first epidemic wave crossed France in March / April 2020 then a second in October / November with a source of contamination which began in mid-August 2020. The sources of propagation are not well known (what places, what times, what contacts…? ) In the context of the health crisis linked to the coronavirus, knowledge of the sources of propagation of this 2nd wave is an important issue to guide end of lockdown and second lockdown policies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| users | users of web-application |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| users | Other | Data of users of the web-application |
|
| Measure | Description | Time Frame |
|---|---|---|
| Description of the methods of contamination of patients | Data and symptomes collected by the web applications self-questionnaire (patient reported outcome) | 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation in time of the spread of the virus during the 2nd epidemic wave. | Data and symptomes collected by the web applications self-questionnaire (patient reported outcome) | 2 months |
| Evaluation in space of the spread of the virus during the 2nd epidemic wave. |
Not provided
Inclusion criteria:
Exclusion criteria:
- user who does not have a complete questionnaire
Not provided
Not provided
Not provided
All users of the application contaminated with COVID 19 who have not objected to the use of their data
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Fabrice DENIS, MD | Institut Interrégional de Cancerologie et Kelindi | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Institut Interrégional de Cancérologie | Le Mans | 72000 | France |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33878018 | Derived | Denis F, Septans AL, Le Goff F, Jeanneau S, Lescure FX. Analysis of COVID-19 Transmission Sources in France by Self-Assessment Before and After the Partial Lockdown: Observational Study. J Med Internet Res. 2021 May 4;23(5):e26932. doi: 10.2196/26932. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Data and symptomes collected by the web applications self-questionnaire according to ZIP code (patient reported outcome) |
| 2 months |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |